-
181
The ability of natural tolerance to be applied to allogeneic tissue: determinants and limits
Published 2007-04-01“…<p>Abstract</p> <p>Background</p> <p>Transplant rejection has been considered to occur primarily because donor antigens are not present during the development of the recipient's immune system to induce tolerance. …”
Get full text
Article -
182
CD200:CD200R Interactions and Their Importance in Immunoregulation
Published 2021-02-01“…The molecule CD200, described many years ago as a naturally occurring immunomodulatory agent, capable of regulating inflammation and transplant rejection, has attracted additional interest over the past years with the realization that it may also serve as an important marker for progressive malignancy. …”
Get full text
Article -
183
Implantable Immunosuppressant Delivery to Prevent Rejection in Transplantation
Published 2022-01-01“…Collectively, this review will help relevant readers understand the different approaches to prevent transplant rejection in a new era of therapeutic agent delivery.…”
Get full text
Article -
184
Degeneration of Bioprosthetic Heart Valves: Update 2020
Published 2020-10-01“…Recent studies implicate the host immune response as a major modality of SVD pathogenesis, manifested by a combination of processes phenocopying the long‐term transplant rejection, atherosclerosis, and calcification of native aortic valves. …”
Get full text
Article -
185
Polyelectrolyte Coating of Ferumoxytol Differentially Impacts the Labeling of Inflammatory and Steady-State Dendritic Cell Subtypes
Published 2022-12-01“…Functionally distinct DC subsets exist, either under steady-state or inflammatory conditions, which are explored for the specific treatment of various diseases, such as cancer, autoimmunity, and transplant rejection. Here, the impact of the PE coating of ferumoxytol for uptake into both inflammatory and steady-state DCs and the cellular responses to MNP labeling is addressed. …”
Get full text
Article -
186
Therapeutic Antibodies in Cancer Treatment in the UK
Published 2022-11-01“…Oncology, autoimmune diseases and to a smaller degree the prophylaxis of organ transplant rejection are their main application areas. As of the date of this review, 37 monoclonal antibody products are approved for use in cancer treatments in the United Kingdom. …”
Get full text
Article -
187
The Reasons for Refusing Kidney Transplantation Among Iranian Patients Undergoing Peritoneal Dialysis
Published 2022-08-01“…According to patients, kidney transplantation is a long-term procedure that causes financial stress and physical and social problems and there is a risk of transplant rejection. On the other hand, patients were accustomed to performing PD and considered it a part of their life. …”
Get full text
Article -
188
Ocular surface complications following biological therapy for cancer
Published 2023-06-01“…Dry eye, Stevens-Johnson syndrome, and corneal transplant rejection have all been reported following the use of immune checkpoint inhibitors. …”
Get full text
Article -
189
SODIUM REABSORPTION ESTIMATION FOR EVALUATION OF FUNCTIONAL STATE OF TRANSPLANTED KIDNEY
Published 2009-06-01“…In the group of recipients with chronic transplant rejection a free member of regression equation was significantly higher, than in health volunteers (р < 0,01). …”
Get full text
Article -
190
The challenges of managing psychiatric disorders in children with kidney transplant and end-stage renal disease: A case report
Published 2021-04-01“…Moreover, his medical history includes CRS (congenital renal disease), kidney transplant at the age of 2 followed with transplant rejection in 2019. Currently he is under haemodialysis and multiple drug prescriptions associated with his severe medical condition which interferes with the psychotropic treatment. …”
Get full text
Article -
191
Non-invasive Biomarkers of Acute Rejection in Kidney Transplantation: Novel Targets and Strategies
Published 2019-01-01“…Here, we provide an overview of the current status on research of biomarkers of acute kidney transplant rejection in blood and urine. We specifically discuss relatively novel research strategies in biomarker research, including transcriptomics and proteomics, and elaborate on donor-derived cell-free DNA as a potential biomarker.…”
Get full text
Article -
192
Lymphatic vessels in vascularized human corneas: immunohistochemical investigation using LYVE-1 and podoplanin.
Published 2002“…METHODS: Human corneas exhibiting neovascularization secondary to keratitis, transplant rejection, trauma, and limbal insufficiency (n = 21) were assessed for lymphatic vessel content by conventional transmission electron microscopy and by immunostaining and immunoelectron microscopy with antibodies specific for the lymphatic endothelial markers, lymphatic vessel endothelial hyaluronan receptor (LYVE-1) and the 38-kDa integral membrane glycoprotein podoplanin. …”
Journal article -
193
Anti-CD4-mediated selection of Treg in vitro - in vitro suppression does not predict in vivo capacity to prevent graft rejection.
Published 2008“…Regulatory T cells (Treg) have been shown to play a role in the prevention of autoimmune diseases and transplant rejection. Based on an established protocol known to generate alloantigen reactive Treg in vivo, we have developed a strategy for the in vitro selection of Treg. …”
Journal article -
194
Characterising the immune response to combined skin and solid organ transplants
Published 2022“…Finally in Chapter 6 a human transgenic mouse model is used to explore the role of Langerhans cell related pathways in skin transplant rejection.</p> <p>This is the first study to characterise both the systemic and local immune response in a combined skin and solid organ transplant, offering unique insights into the dynamic changes in immune phenotype post-transplantation and during rejection. …”
Thesis -
195
Prospects of the Use of Cell Therapy to Induce Immune Tolerance
Published 2020-05-01“…Conditions in which abnormal or excessive immune responses exist, such as autoimmune diseases (ADs), graft-versus-host disease, transplant rejection, and hypersensitivity reactions, are serious hazards to human health and well-being. …”
Get full text
Article -
196
Anti-CD45RC antibody immunotherapy prevents and treats experimental autoimmune polyendocrinopathy–candidiasis–ectodermal dystrophy syndrome
Published 2022-04-01“…Targeted monoclonal antibody (mAb) therapies show great promise for the treatment of transplant rejection and autoimmune diseases by inducing more specific immunomodulatory effects than broadly immunosuppressive drugs routinely used. …”
Get full text
Article -
197
A Safety and Tolerability Study of Thin Film Freeze-Dried Tacrolimus for Local Pulmonary Drug Delivery in Human Subjects
Published 2021-05-01“…Previous studies reported that inhaled TAC combined with 50% <i>w/w</i> lactose (LAC) was safe and effective for the treatment of lung transplant rejection in rodent models. In this study, we aimed to investigate the safety and tolerability of TFF TAC-LAC in human subjects. …”
Get full text
Article -
198
FIRST EXPERIENCE WITH HEART TRANSPLANTATION IN KRASNODAR REGION
Published 2012-09-01“…Causes of death were septic complications, thromboembolia of the pulmonary artery, severe pancreatonecrosis, and transplant rejection due to non-compliance with immunosuppression therapy, heart rhythm disturbances. …”
Get full text
Article -
199
Kidney Transplantation and Diagnostic Imaging: The Early Days and Future Advancements of Transplant Surgery
Published 2020-12-01“…In the years thereafter, kidney transplantation and diagnostic imaging followed a synergistic path for their development, with key discoveries in transplant rejection pathways, immunosuppressive therapies, and the integration of diagnostic imaging in transplant programs. …”
Get full text
Article -
200
THE LEVEL OF DENDRITIC CELLS IN KIDNEY TRANSPLANT RECIPIENTS IN THE EARLY POSTOPERATIVE PERIOD
Published 2020-06-01“…The patients were divided into groups: PGF – those with satisfactory primary graft function, PGD – those with primary graft dysfunction, TR – those with transplant rejection in the postoperative period. The comparison group (CG) consisted of healthy volunteers. …”
Get full text
Article